Albay, A. Et Al. 2019. Domain I of beta 2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation. LUPUS , vol.28, no.7 , 893-897.

Albay, A., Artim-Esen, B., PERICLEOUS, C., Wincup, C., Giles, I., Rahman, A., ... McDonnell, T.(2019). Domain I of beta 2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation. LUPUS , vol.28, no.7, 893-897.

Albay, A. Et Al. "Domain I of beta 2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation," LUPUS , vol.28, no.7, 893-897, 2019

Albay, A. Et Al. "Domain I of beta 2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation." LUPUS , vol.28, no.7, pp.893-897, 2019

Albay, A. Et Al. (2019) . "Domain I of beta 2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation." LUPUS , vol.28, no.7, pp.893-897.

@article{article, author={A. Albay Et Al. }, title={Domain I of beta 2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation}, journal={LUPUS}, year=2019, pages={893-897} }